Skip to content

Korea
World
Technology
Business
Sports
Entertainment
Health

Korea
World
Technology
Business
Sports
Entertainment
Health

SGLT-2 inhibitor

‘Possiga’ changes the paradigm for chronic heart failure treatment

‘Possiga’ changes the paradigm for chronic heart failure treatment

‘Possiga’ changes the paradigm for chronic heart failure treatment

‘Possiga’ changes the paradigm for chronic heart failure treatment

‘Possigar’ added indication for chronic heart failure

‘Possigar’ added indication for chronic heart failure

footer

Contact Us
Sitemap
News-Sitemap

© 2025 Aju.News/en